Milford, MA, United States of America

James Woiszwillo


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 57(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of James Woiszwillo

Introduction

James Woiszwillo is an accomplished inventor based in Milford, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. His work has led to the creation of a unique patent that showcases his expertise and dedication to advancing medical technology.

Latest Patents

Woiszwillo holds a patent for "Lyophilized compositions, preparation and use thereof." This invention involves a syringe containing a lyophilized mixture of absorbable gelatin powder and aminocaproic acid. The preparation process includes mixing the gelatin powder, aminocaproic acid, and water to form a slurry, which is then introduced into a syringe and freeze-dried. This innovative approach enhances the stability and efficacy of the drug formulation.

Career Highlights

James Woiszwillo is currently employed at Serono Pharmaceutical Partners, where he continues to push the boundaries of pharmaceutical innovation. His work at the company has been instrumental in developing new therapeutic solutions that improve patient outcomes. With a focus on research and development, Woiszwillo has established himself as a key player in the pharmaceutical industry.

Collaborations

Woiszwillo collaborates with talented professionals in his field, including Grace Wood and Benjamin R Duce. These partnerships foster a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in pharmaceutical technology.

Conclusion

James Woiszwillo's contributions to the field of pharmaceuticals through his innovative patent and collaborative efforts highlight his commitment to improving medical treatments. His work continues to inspire advancements in drug delivery systems, ultimately benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…